CDKN2A and neoplasm: In fact, some studies suggest that p16INK4a overexpression could be related to unfavorable tumor characteristics in a subset of tumors, including adenocarcinoma, breast cancer, astrocytoma, and gastrointestinal stromal tumors [44,45,47,69].